* 1. Name (optional)

* 2. What is your discipline?

* 3. How did you hear about this meeting?

* 4. Have you been involved with submitting an FDA orphan product grant?

* 5. Have you been involved with submitting a previous request for orphan drug designation to the FDA or EMA?

T